<DOC>
	<DOC>NCT00984295</DOC>
	<brief_summary>This study will assess the safety and immunogenicity of ProQuad when administered concomitantly and nonconcomitantly with Tripedia and Comvax.</brief_summary>
	<brief_title>Frozen ProQuad Administered Concomitantly Versus Nonconcomitantly With Other Pediatric Vaccines</brief_title>
	<detailed_description />
	<mesh_term>Rubella</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>In good health Negative clinical history of varicella, zoster, measles, mumps, rubella, diptheria, tetanus, pertussis, invasive Hib disease and hepatitis B Had completed either a 2dose primary series of PedvaxHIB or COMVAX or any 3dose primary series of a licensed Hib vaccine Had received 2 or 3 doses of any hepatitis B vaccine or COMVAX prior to entry into trial Previous receipt of measles, mumps, rubella or varicella vaccine either alone or in combination Any immune impairment or deficiency Recent household, daycare or school exposure to invasive Hib disease or hepatitis B Exposure to measles, mumps, rubella, varicella, or zoster in the 4 weeks prior to vaccination Vaccination with an inactive vaccine with in the past 14 days Vaccination with a live vaccine within the past 30 days Receipt of immune globulin, blood transfusion or bloodderived product in the past 3 months Recent history of fever or underlying medical problems</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>15 Months</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>